[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Inzitari
D
D
I Clinica Neurologica, Università di Firenze.
Fratiglioni
L
L
Baldereschi
M
M
Candelise
L
L
Anzalone
N
N
Bonatti
M L
ML
Prencipe
M
M
Gandolfo
C
C
Mamoli
A
A
Rasura
M
M
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000925:Anticoagulants; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Gruppo di studio "Valutazione dell'efficacia dei trattamenti terapeutici nelle malattie cerebro-vascolari".